News

Comvest Credit Partners Launches $500 Million CLO for Investors

Comvest Credit Partners Launches $500 Million CLO for Investors

Comvest Credit Partners Celebrates the Closing of Its First Middle-Market CLO

Comvest Credit Partners, a leading provider of customized financing solutions for middle-market companies, has reached a notable milestone by successfully closing its first-ever Collateralized Loan Obligation (CLO), named Comvest 2024-1 CLO, at an impressive $500 million. This achievement not only adds to Comvest's portfolio but also underscores their commitment to offering a variety of investment opportunities.

Exploring the Features and Advantages of the CLO

The Comvest CLO aims to strengthen the firm’s offerings in the credit investment arena, providing a solid option for investors seeking to diversify their portfolios. Jason Gelberd, a Partner and Chief Operating Officer at Comvest, shared his excitement about the CLO, highlighting its essential role in broadening their credit product range.

Assurances from Comvest Leadership

Jason Gelberd remarked, "We are excited to leverage Comvest's resources and capabilities to enhance our credit product offerings. The CLO showcases our extensive expertise in managing middle-market credit investments, presenting investors with diverse opportunities to engage with Comvest.” His words reflect a strong confidence in the firm’s ability to deliver returns for its investors.

Positive Investor Reception and Market Perspective

The response from investors regarding Comvest’s inaugural CLO has been overwhelmingly positive, demonstrating trust in Comvest's experienced credit investment team and their impressive track record that spans nearly two decades. Gelberd noted the encouraging feedback from their investor community and expressed aspirations to return to the market as a programmatic CLO issuer in the future.

A Distinct Investment Opportunity

The Comvest CLO is rated by Standard & Poor’s and is backed by a diversified portfolio of senior secured loans that are both originated and managed by Comvest. With a nine-month reinvestment period and a nine-month non-call period, this CLO provides investors with a structured and dependable investment pathway.

Strategic Partnerships Strengthening Operations

To facilitate this significant transaction, Deutsche Bank Securities Inc. acted as the Lead Manager and Sole Bookrunner, while NatWest Markets plc served as the Co-Placement Agent alongside GreensLedge Capital Markets LLC, which functioned as the Co-Manager. These collaborations further highlight Comvest's strategic approach to enhancing its funding sources.

Leading the Market

With the closing of the Comvest CLO, the firm has established itself as the first debut issuer of a middle-market U.S. CLO in 2024, marking a noteworthy accomplishment in the competitive landscape of CLO issuers. This milestone not only signifies Comvest’s growth but also its dedication to innovation within the financing sector.

About Comvest Credit Partners

Comvest Credit Partners, the direct lending division of Comvest Partners, is committed to providing flexible, high-quality financing solutions to middle-market companies. Their focus includes a range of financial needs such as senior secured, unitranche, and second lien capital, aimed at supporting growth, acquisitions, buyouts, refinancings, and recapitalizations, with credit facilities exceeding $300 million.

About Comvest Partners

Founded in 2000, Comvest Partners is a private investment firm that has delivered both equity and debt capital tailored for well-positioned middle-market companies across North America. Comvest is well-regarded for its operational expertise, collaborative approach, and extensive transaction experience, managing $12.5 billion in assets and investing over $13.5 billion since its inception. With headquarters in West Palm Beach, the firm also maintains offices in Chicago and New York City.

Frequently Asked Questions

What is the total amount of the CLO closed by Comvest?

The Comvest CLO was closed at $500 million, marking a significant achievement for the firm.

What types of loans does the Comvest CLO focus on?

The CLO is collateralized by a diversified portfolio of senior secured loans originated and managed by Comvest.

Who managed the transaction for the CLO?

Deutsche Bank Securities Inc. served as the Lead Manager and Sole Bookrunner, while NatWest Markets and GreensLedge Capital Markets acted as co-managers.

How long is the reinvestment period for the CLO?

The CLO features a nine-month reinvestment period and a nine-month non-call period for investors.

What is Comvest's specialty in financing?

Comvest provides senior secured, unitranche, and second lien capital to support a variety of financial activities including growth and acquisitions for middle-market companies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Nonprofit and Partners Gift Homes to Veterans

Updated Category News Views 100

A Heartfelt Gesture on Veterans Day Now this is the kind of story that gets you right in the gut. On November 9, two veterans, who were likely walking into a golf club thinking it was just another evening, were handed the keys to a future they might have only dreamt of: a mortgage-free home. Operation Finally Home, backed by the big names like Lennar and the patriotic...

Continue Reading
Surprising Week on Wall Street: Chips Drive Gains

Updated Category News Views 141

A Wild Week in Wall Street Well, folks, what a week it’s been on Wall Street. The indexes danced the cha-cha, making gains despite closing Friday on a lower note. Despite the retreat, we've got ourselves a week where the major indexes closed higher than the previous Friday. It's not the usual story, but who ever thought stocks played by the rules? The Nasdaq Composite...

Continue Reading
Manhattan Associates Faces Investigation by KSF Law Firm

Updated Category News Views 141

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 83

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
LA Fitness ELEVATE Opens at RITHM: A New Era Dawns

Updated Category News Views 66

Elevating Fitness at RITHM: A New Era Has Begun RD Management just dropped a new ace in Tampa Bay’s hand—LA Fitness ELEVATE at the RITHM at Uptown. They lit up the scene with this 30,000-square-foot beast of a gym, and I’ll tell you, it’s not your standard run-of-the-mill joint. When you toss twelve-and-a-half million bucks into a pot, you're aiming to lure folks...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 99

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 155

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Gemmy's Holiday Lights: Bright Ideas for 2026

Updated Category News Views 149

Deep in the heart of Dallas, Gemmy Industries is out to sprinkle a bit of magic over the holiday season for 2026. This ain't your grandma's string lights we're talkin' about here. We're diving headfirst into a new world of seasonal decor with tech-driven lights that look like they came straight outta a winter wonderland. And hey, if Walmart's set to host this lineup, you...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 177

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading

Top 5 Most Recently Viewed Articles

NexPoint Capital Launches Tender Offer for Shareholders

Updated Category News Views 217

NexPoint Capital Begins Tender Offer for Its Common Stock NexPoint Capital, Inc. (the "Company"), a publicly registered business development company expertly managed by NexPoint Advisors, L.P., is set to kick off a voluntary tender offer aimed at going after up to 2.5% of its outstanding common shares. This offer is designed to provide shareholders an opportunity to sell...

Continue Reading
Experience the Winter Wheat Wonderland Pop-Up by Maker's Mark

Updated Category News Views 223

Immerse Yourself in Maker's Mark's Winter Wheat Wonderland Get ready to experience something truly unique this holiday season as Maker's Mark unveils its enchanting pop-up event, the Winter Wheat Wonderland. This special event will take the vibrant spirit of Kentucky bourbon to the heart of New York City, creating a magical atmosphere for all attendees. Details of the...

Continue Reading
Innovative Muscle Composition Study Enhances Liver Transplant Care

Updated Category News Views 202

Assessment of Muscle Composition in Liver Transplant Candidates In a groundbreaking study, the utilization of AMRA Profiler 4, an advanced body-composition analysis device, was analyzed for its effectiveness in evaluating muscle composition among liver transplant candidates suffering from end-stage liver disease (ESLD). This study aims to shed light on critical health...

Continue Reading
Hansa Biopharma's Major Milestones Anticipated in 2025

Updated Category News Views 688

Hansa Biopharma's Participation in Healthcare Conferences Hansa Biopharma AB, a pioneering biopharmaceutical company, is set to make a significant presence at the 2025 J.P. Morgan Healthcare Conference. The company is renowned for its innovative approaches in addressing rare immunological disorders and has been actively engaged in developing novel therapies. This...

Continue Reading
AI for Customer Service: The Next Big Market Leap Ahead

Updated Category News Views 137

AI for Customer Service Market Growth Overview The AI for customer service market is on a remarkable trajectory, set to expand significantly over the next few years. Current projections indicate that the market size will grow from USD 12.06 billion in the near term to an impressive USD 47.82 billion by the end of the decade, achieving a compound annual growth rate (CAGR)...

Continue Reading